(T) (202) 789-6090

  mduvall@bdlaw.com
  vCard

1350 I Street, N.W.
Suite 700
Washington, DC 20005-3311
Washington

• Alternative Energy - Environmental
• Biotechnology
• Consumer Products Practice
• Emergency Planning and Community Right-to-Know
• FDA Practice
• Global Product Stewardship
• International Environmental Law
• Nanotechnology
• Pesticides
• Product Regulation and Litigation Practice
• Toxic and Harmful Substances/TSCA
• Voluntary Initiatives and Programs
• Workplace Health and Safety

• Amherst College (B.A., magna cum laude, 1974; Phi Beta Kappa)
• University of Virginia School of Law (J.D., 1978; Order of the Coif)

• State Bars: District of Columbia; Connecticut; Michigan
• Federal Appellate Courts: U.S. Supreme Court; U.S. Court of Appeals for the District of Columbia and Fifth Circuits
• U.S. District Courts: District of Columbia

Mark Duvall joined Beveridge & Diamond, P.C. in 2008 as a Principal with over two decades of experience working in-house at large chemical companies.  His focus has been on product regulation at the federal, state, and international levels across a wide range of programs, and worker health and safety. 

He heads the Firm’s Toxic and Harmful Substances/Toxic Substances Control Act (“TSCA”) practice.  His experience under TSCA includes enforcement actions, counseling, rulemaking, advocacy, and legislative actions.  He chairs the TSCA Dialogue Group, an informal group of companies that manufacture, import, distribute, and/or sell chemicals, and related trade associations, that address possible legislation to amend TSCA and alternatives to legislation.  He also has worked with counterparts to TSCA in Canada and Europe.

He has extensive experience with the Federal Insecticide, Fungicide, and Rodenticide Act (“FIFRA”), particularly with respect to regulation of antimicrobials, and with the Biocidal Products Directive in Europe.

He heads the Firm’s FDA practice group, having worked on FDA regulation of food and food additives, dietary supplements, drugs, medical devices, and cosmetics, and European counterparts.  He is knowledgeable about human testing requirements, having served as the Chair of an institutional review board for several years.

He has counseled clients on the regulation of consumer products by the Consumer Product Safety Commission and the Federal Trade Commission.  He has reviewed hundreds of green marketing claims and counseled on federal, state, and international regulation of such claims.

He has worked on green chemistry issues at the federal and state levels, as well as a variety of voluntary programs that affect products.  He has experience with the Emergency Planning and Community Right-to-Know Act (“EPCRA”), the Chemical Weapons Convention, and other chemicals-related requirements.

He has advised clients and written and lectured on regulation of the products of nanotechnology by FDA and by EPA under FIFRA and TSCA, and on related product stewardship issues.

He heads the Firm’s Workplace Health and Safety practice.  He has extensive experience with OSHA inspections, enforcement litigation, compliance counseling, advocacy, and rulemaking, with particular emphasis on process safety.  He has counseled clients on the EPA risk management program (“RMP") requirements under Section 112(r) of the Clean Air Act and state worker protection programs, and on inspections by the Chemical Safety and Health Investigation Board (“CSB”).

He is Chair of the Committee on Pesticides, Chemical Regulation, and Right-to-Know of the American Bar Association’s Section on Environment, Energy, and Resources.